Tag: NASDAQ:ALLK

October 15, 2019

Pharma Market Update: Q3 2019 in Review

With Q3 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
January 29, 2019

Allakos Announces Positive Phase 2 Results in Patients with Cholinergic Urticaria and Symptomatic Dermographism

Allakos (NASDAQ:ALLK), a biotechnology company developing AK002 for the treatment of eosinophil and mast cell related diseases, today announced positive...
August 7, 2018

4 Biotechnology IPOs in July

The Investing News Network provides a look back at four biotechnology stocks that launched on the NASDAQ during the month...